CDRH Is Testing New Decision Methods That Could “Change Everything”
FDA's device center is pursuing a pilot study of "quantitative" methods for evaluating data that some say could be the beginning of a complete overhaul in the way regulatory decisions are made
More from Archive
More from Medtech Insight
Germany’s electronic patient record – ePA – is a flagship initiative of the ongoing national healthcare reform. The medtech industry welcomes rollout of the ePA while calling for further improvements.
An interactive look at recent executive-level company changes and promotions in the medical device and diagnostics industries.
EirMed CEO Richard Houlihan warns that EUDAMED (the European database on medical devices) publication delays may harm medical device manufacturers. Currently, only a fraction of the required uploads have occurred, creating potential compliance risks as the mandatory deadline approaches.